Agenus Inc (NASDAQ:AGEN)
During the Trading Day
| 4.03 |  +0.02 / +0.50% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 4.03 |  0.00 / 0.00% |
Volume: 1.8K |
Latest AGEN News | Press Releases
No recent news for Agenus Inc.
Today’s Trading
| Previous close | 4.01 |
| Today’s open | 4.02 |
| Day’s range | 4.00 - 4.23 |
| Volume | 167,024 |
| Average volume (3 months) | 160,692 |
| Market cap | $91.2M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/22/2013
Growth & Valuation
| Earnings growth (last year) | +57.85% |
| Earnings growth (this year) | -88.63% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +479.17% |
| P/E ratio | NM |
| Price/Sales | 6.07 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BCRXBioCryst Pharmaceuti... | -0.02 | -1.18% |
| CURNeuralstem Inc | 0.00 | 0.00% |
| PIPPharmAthene Inc | -0.00 | -0.30% |
| CYTRCytRx Corp | -0.11 | -4.55% |
Data as of 4:00pm ET, 05/22/2013
Financials
| Next reporting date | August 1, 2013 |
| EPS forecast (this quarter) | -$0.22 |
| Annual revenue (last year) | $16.0M |
| Annual profit (last year) | -$11.3M |
| Net profit margin | -70.95% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Garo H. Armen, PhD |
VP, Chief Financial & Accounting Officer Christine M. Klaskin, CPA |
Corporate headquarters Lexington, Massachusetts |
Forecasts
